Who owns Ariad Pharmaceuticals?

Key details on Ariad Pharmaceuticals (Ticker: ARIA)

Who owns Ariad Pharmaceuticals?

Is ARIA a good stock to own? Find out who bought Ariad Pharmaceuticals, who sold Ariad Pharmaceuticals (ARIA) stock, and who holds a large position in Ariad Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
Sarissa Capital Management 12.85M $106.27M June 30, 2015
Vanguard 11.54M $95.42M June 30, 2015
PUTNAM INVESTMENTS 10.56M $86.99M March 31, 2015
Artisan Partners Limited Partnership 9.80M $171.37M June 30, 2013
Westfield Capital Management Company 9.16M $75.78M June 30, 2015
GOLDMAN SACHS 8.46M $155.75M Sept. 30, 2013
FMR 8.37M $69.20M June 30, 2015
BlackRock Fund Advisors 8.28M $68.47M June 30, 2015
Camber Capital Management 7.50M $51.52M Dec. 31, 2014
Adage Capital Partners GP 6.67M $53.75M March 31, 2014
Slate Path Capital 6.62M $53.36M March 31, 2014
STATE STREET CORPORATION 6.09M $50.35M June 30, 2015
Discovery Capital Management 5.84M $48.14M March 31, 2015
Waddell & Reed Financial 5.75M $105.87M Sept. 30, 2013
Ameriprise Financial 5.46M $100.41M Sept. 30, 2013
Neuberger Berman 5.44M $100.07M Sept. 30, 2013
Columbia Wanger Asset Management 5.29M $97.35M Sept. 30, 2013
Franklin Resources 5.04M $32.09M June 30, 2014
S.A.C. Capital Advisors 4.94M $119.62M Sept. 30, 2012
T. Rowe Price Associates 4.77M $86.34M March 31, 2013
BlackRock Institutional Trust Company, N.A. 4.66M $38.58M June 30, 2015
Damian Sousa 4.54M $84.80M Sept. 30, 2013
PointState Capital 4.50M $37.08M March 31, 2015
Renaissance Technologies 4.40M $28.03M June 30, 2014
Janus Capital Management 4.20M $73.39M June 30, 2013
AQR Capital Management 3.88M $24.73M June 30, 2014
BB Biotech AG 3.69M $67.88M Sept. 30, 2013
Barclays 3.67M $58.60M March 31, 2012
SUSQUEHANNA INTERNATIONAL 3.61M $19.50M Sept. 30, 2014
TimesSquare Capital Management 3.59M $62.87M June 30, 2013
Federated Investors 3.47M $63.76M Sept. 30, 2013
Palo Alto Investors 3.46M $27.88M March 31, 2014
Perceptive Advisors 3.08M $37.70M Dec. 31, 2011
Sectoral Asset Management 3.01M $55.36M Sept. 30, 2013

Who sold Ariad Pharmaceuticals?

Fund Name Date Sold Number of Shares Sold Share Valuation
Jennison Associates March 31, 2011 3.59M $27.00M